BIOMAT Database Logo BIOMAT Database Logo

Subnormal plasma von Willebrand factor (ristocetin cofactor) and iron deficiency anaemia in menstruating women. 1996

E A Beck, and C Limoni

UI MeSH Term Description Entries
D008297 Male Males
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D018798 Anemia, Iron-Deficiency Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased. Iron-Deficiency Anemia,Anemias, Iron-Deficiency,Iron-Deficiency Anemias,Anemia, Iron Deficiency,Anemias, Iron Deficiency,Iron Deficiency Anemia,Iron Deficiency Anemias

Related Publications

E A Beck, and C Limoni
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
October 2008, Journal of thrombosis and thrombolysis,
E A Beck, and C Limoni
Plasma derived von Willebrand factor preparations: collagen binding and ristocetin cofactor activities.
August 1997, Thrombosis and haemostasis,
E A Beck, and C Limoni
Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
January 2017, Methods in molecular biology (Clifton, N.J.),
E A Beck, and C Limoni
Letter: A method for assaying von Willebrand factor (ristocetin cofactor).
September 1975, Thrombosis et diathesis haemorrhagica,
E A Beck, and C Limoni
Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
June 1988, Thrombosis and haemostasis,
E A Beck, and C Limoni
Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA.
January 2005, Thrombosis and haemostasis,
E A Beck, and C Limoni
[von Willebrand factor (antigen and activity), multimer structure, and ristocetin cofactor activity].
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
E A Beck, and C Limoni
Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation.
February 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
E A Beck, and C Limoni
[Measurement of von Willebrand factor antigen, multimer structure and ristocetin cofactor activities].
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
E A Beck, and C Limoni
A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry.
February 2008, Journal of thrombosis and haemostasis : JTH,
Copied contents to your clipboard!